Low molecular weight heparin: does it represent a clinical opportunity for preventing preeclampisa associated with fetal growth restriction?

New lenses to look at preeclampsia

“…This explains why LMWH worked better in trials focused on early severe HDP associated with IUGR. LMWH should be considered to prevent the recurrence of HDP-IUGR, or in other terms the HDP of placental origin [35][36][37][38][39].…”